Long-term survival rate of pediatric patients after blood transfusion

France Gauvin1, Martin A Champagne, Pierre Robillard

  • 1Pediatric Intensive Care Unit, Department of Pediatrics, CHU Sainte-Justine, Université de Montréal, Montréal, Québec, Canada. france_gauvin@ssss.gouv.qc.ca

Transfusion
|January 23, 2008
PubMed

Insights

Pediatric posttransfusion survival rates are higher than in adults, with most deaths occurring early. Key risk factors for mortality in children include young age, malignant disease, and multiple transfusions.

Area of Science:

  • Pediatric Hematology
  • Transfusion Medicine
  • Clinical Outcomes Research

Background:

  • Adult posttransfusion survival rates (PTSR) range from 41-67% at 1-10 years.
  • Limited data exists on PTSR specifically in pediatric populations.
  • This study addresses PTSR and mortality risk factors in children receiving transfusions.

Purpose of the Study:

  • To evaluate posttransfusion survival rates in pediatric patients.
  • To identify risk factors associated with death in children undergoing transfusions.
  • To compare pediatric PTSR with previously reported adult data.

Main Methods:

  • Retrospective analysis of 1100 children receiving their first transfusion between 1990-1992.
  • Data collected included demographics, diagnoses, surgical procedures, and transfusion details.
  • Death confirmation utilized hospital, provincial, and death certificate databases.

Main Results:

  • 1-year PTSR was 86.9%, and 10-year PTSR was 82.3%.
  • Median survival for non-survivors was 22 days.
  • Risk factors for mortality included age <1 month, malignant disease, >20 transfusions, and multiple component types.

Conclusions:

  • Pediatric PTSR is significantly higher than in adults.
  • Mortality risk is concentrated in the early post-transfusion period.
  • Survival rates stabilize after the initial period following transfusion.
Abstract

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...